27 related articles for article (PubMed ID: 21933797)
1. Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.
Sicouri S; Cordeiro JM; Talarico M; Antzelevitch C
J Cardiovasc Electrophysiol; 2011 Jun; 22(6):698-705. PubMed ID: 21159010
[TBL] [Abstract][Full Text] [Related]
2. The frequency of atrial fibrillatory waves is modulated by the spatiotemporal pattern of acetylcholine release: a 3D computational study.
Celotto C; Sánchez C; Abdollahpur M; Sandberg F; Rodriguez Mstas JF; Laguna P; Pueyo E
Front Physiol; 2023; 14():1189464. PubMed ID: 38235381
[TBL] [Abstract][Full Text] [Related]
3. Impact of bisoprolol transdermal patch on early recurrence during the blanking period after atrial fibrillation ablation.
Suzuki Y; Kuroda M; Fujioka T; Kintsu M; Noda T; Matsumoto A; Kawata M
J Arrhythm; 2021 Jun; 37(3):607-615. PubMed ID: 34141013
[TBL] [Abstract][Full Text] [Related]
4. An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias.
Niu G; Scherlag BJ; Lu Z; Ghias M; Zhang Y; Patterson E; Dasari TW; Zacharias S; Lazzara R; Jackman WM; Po SS
Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):384-92. PubMed ID: 19808494
[TBL] [Abstract][Full Text] [Related]
5. An acute model for atrial fibrillation arising from a peripheral atrial site: evidence for primary and secondary triggers.
Scherlag BJ; Hou YL; Lin J; Lu Z; Zacharias S; Dasari T; Niu G; Ghias M; Patterson E; Jackman WM; Lazzara R; Po SS
J Cardiovasc Electrophysiol; 2008 May; 19(5):519-27. PubMed ID: 18266671
[TBL] [Abstract][Full Text] [Related]
6. Differential densities of muscarinic acetylcholine receptor and I(K,ACh) in canine supraventricular tissues and the effect of amiodarone on cholinergic atrial fibrillation and I(K,ACh).
Huang CX; Zhao QY; Liang JJ; Chen H; Yang B; Jiang H; Li GS
Cardiology; 2006; 106(1):36-43. PubMed ID: 16612067
[TBL] [Abstract][Full Text] [Related]
7. The role of ganglionated plexi in apnea-related atrial fibrillation.
Ghias M; Scherlag BJ; Lu Z; Niu G; Moers A; Jackman WM; Lazzara R; Po SS
J Am Coll Cardiol; 2009 Nov; 54(22):2075-83. PubMed ID: 19926016
[TBL] [Abstract][Full Text] [Related]
8. Inducibility of atrial fibrillation after GP ablations and "autonomic blockade": evidence for the pathophysiological role of the nonadrenergic and noncholinergic neurotransmitters.
Liu Y; Scherlag BJ; Fan Y; Varma V; Male S; Chaudhry MA; Huang C; Po SS
J Cardiovasc Electrophysiol; 2013 Feb; 24(2):188-95. PubMed ID: 23066921
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological prevention and termination of focal atrial fibrillation.
Moers AM; Scherlag BJ; Niu G; Lu Z; Ghias M; Lazzara R; Jackman WM; Po SS
Europace; 2012 Mar; 14(3):426-30. PubMed ID: 21933797
[TBL] [Abstract][Full Text] [Related]
10. Pilsicainide for atrial fibrillation.
Kumagai K; Nakashima H; Tojo H; Yasuda T; Noguchi H; Matsumoto N; Ogawa M; Saku K
Drugs; 2006; 66(16):2067-73. PubMed ID: 17112301
[TBL] [Abstract][Full Text] [Related]
11. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
12. The pharmacologic treatment of atrial fibrillation.
Bolognesi R
Cardiovasc Drugs Ther; 1991 Jun; 5(3):617-28. PubMed ID: 1678964
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
